conjectur market whether edward decemb slower month us transcathet aortic
valv tavr busi tavr sale nearli underli basi manag estim us procedur
approxim growth compar ou procedur high-teen decemb slow imag
number would expect hear commentari call
manag rais low end overal sale guidanc rang billion billion street billion
comment tavr sale growth guidanc releas howev comment confer call on-going expect
tavr sale growth top end rang high end tavr rang billion vs prior
billion tavr sale underli basi ep came light rel consensu vs street
within guidanc rang howev stop manag rais ep rang
street
revert back call net/net hard fight tide one clearli good quarter better-than-expect tavr
quarter recent think recent could risk
oo look bloomberg im reach question detail kstew
sale beatslead robust tavr sale ep consensu within guidanc
sale ere billion bloomberg billion barclay billion edw ard guidanc
adjust ep ere bloomberg barclay edw ardss guidanc
tavr sale ere hich ere streetaccount estim million estim million
underli tavr sale growth ew estim us procedur ere y/i ou procedur ere
high-teen ou procedur grow th compar region edw ard note global averag sell price
transcathet mitral tricuspid therapi
tmtt revenu ere million streetaccount tmtt estim million in-lin ith
estim million
manag comment sale ere neg impact voluntari pascal field correct action hich someth
 ere expect compani comment could impact quarterli result analyst day decemb
factor impact forecast
surgic structur heart sale ere million ere dow underli basi manag attribut sale
declin low er surgic aortic valv procedur us tavr adopt increas partial off-set adopt premium price
critic sale ere million ere underli basi manag cite strong demand
hemospher advanc monitor platform continu adopt smart recoveri
edw ard turn somew hat rare ep miss rel ith adjust ep consensu albeit still ithin
guidanc rel expect gross margin ere eaker expect sg higher
manag cite sg increas field clinic personnel support tavr case ell acceler action relat diseas
aw are therapi adopt hich view seem ork given continu robust procedur grow th note
edw ard sg expens exclud litig expens relat ip litig quarter pre-tax per
guidanc updat rais low end sale up ep rang
full year manag rais low end total sale guidanc expect sale billion prior rang
billion manag comment transcathet aortic valv replac tavr guidanc rang press
releas rais adjust ep rang
edw ard expect sale billion street billion adjust ep street
kristen stew art cfa herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens
 ill directli indirectli relat specif recommend view express research report
barclay capit inc and/or one affili seek busi ith compani cover research report
result investor aw firm may conflict interest could affect object report investor
consid report singl factor make invest decis
barclay research produc invest bank barclay bank plc affili collect individu
barclay author contribut research report research analyst unless otherw ise indic public date
top report reflect local time report produc may differ releas date provid gmt
avail disclosur
 compani subject research report current import disclosur regard compani pleas
refer http //publicresearch barclay com altern send ritten request barclay research complianc seventh
avenu floor new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ
firm total revenu portion hich gener invest bank activ profit revenu market
busi potenti interest firm invest client research ith respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit
accept payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link
analysi quantit analysi trade idea recommend contain one type barclay research may differ
contain type barclay research hether result differ time horizon methodolog otherw ise
order access barclay statement regard research dissemin polici procedur pleas refer
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas
refer http //publicresearch barcap com/s/cm htm
master limit partnership mlp pass-through entiti structur publicli list partnership tax purpos
distribut unit holder may treat return princip investor consult ow tax advisor
invest unit
valuat methodolog set price target primarili reli forw ard price-to-earnings methodolog believ
multipl ew share ill like compress given potenti slow er grow th believ ill harder increment
penetr tavr market tmtt opportun ill like take longer play price target appli price-to-earnings
multipl ep estim
risk may imped achiev barclay research valuat price greater transcathet aortic
valv replac tavr sale success transcathet mitral tricuspid therapi tmtt could result higher earn
chang reimburs product failur valv thrombosi advers long-term outcom hich may chang usag
trend product patent litig outcom fda govern action
rate price target histori
prior intra-day chang may publish rate secur equal eight
adjust price target
histor stock price price target may adjust stock split dividend
unless otherw ise indic price sourc bloomberg reflect close price relev trade market hich
may last avail price time public
barclay bank plc and/or affili lead manag co-lead manag publicli disclos offer secur
issuer previou month
 employe non-execut director barclay plc director issuer
cd barclay bank plc and/or affili market-mak debt secur issu issuer
ce barclay bank plc and/or affili market-mak equiti secur issu issuer
barclay bank plc and/or affili receiv compens invest bank servic issuer past
 barclay bank plc and/or affili expect receiv intend seek compens invest bank servic
issuer ithin next month
fa barclay bank plc and/or affili benefici ow ns class equiti secur issuer calcul
fb barclay bank plc and/or affili benefici ow ns long posit class equiti secur
issuer calcul accord ith eu regul
fc barclay bank plc and/or affili benefici ow ns short posit class equiti secur
issuer calcul accord ith eu regul
fd barclay bank plc and/or affili benefici ow ns class equiti secur issuer calcul
gd one research analyst fundament credit coverag team member household long
posit common equiti secur issuer
ge one research analyst fundament equiti coverag team member household long
posit common equiti secur issuer
 issuer benefici ow ns class common equiti secur barclay plc
barclay bank plc and/or affili parti agreement ith issuer provis financi servic barclay
bank plc and/or affili
 barclay bank plc and/or affili liquid provid and/or trade regularli secur issuer and/or
 barclay bank plc and/or affili receiv non-invest bank relat compens includ compens
brokerag servic applic issuer ithin past month
 issuer past month invest bank client barclay bank plc and/or affili
issuer past month non-invest bank client secur relat servic barclay
bank plc and/or affili
 issuer past month non-invest bank client non-secur relat servic
barclay bank plc and/or affili
use
 partner director offic barclay capit canada inc preced month provid servic subject
compani remuner normal cours invest advisori trade execut servic
 barclay bank plc and/or affili corpor broker issuer
 barclay capit canada inc and/or affili receiv compens invest bank servic issuer
issuer corpor broker barclay plc
barclay bank plc and/or affili provid equiti advisori servic issuer
 equiti secur canadian issuer includ subordin vote restrict share
 equiti secur canadian issuer includ non-vot restrict share
guid barclay fundament equiti research rate system
coverag analyst use rel rate system hich rate stock overw eight equal eight underw eight see
definit rel compani cover analyst team analyst deem
industri industri coverag univers see list compani compris particular industri coverag univers pleas
go http //publicresearch barclay com
addit stock rate provid industri view hich rate outlook industri coverag univers posit
neutral neg see definit rate system use term buy hold sell equival rate
system investor care read entir research report includ definit rate infer content
rate alon
overweight stock expect outperform unw eight expect total return industri coverag univers
equal weight stock expect perform line ith unw eight expect total return industri coverag univers
invest horizon
underweight stock expect under-perform unw eight expect total return industri coverag univers
rate suspend rate target price suspend temporarili due market event made coverag
impractic compli ith applic regul and/or firm polici certain circumst includ invest
barclay plc act advisori capac merger strateg transact involv compani
posit industri coverag univers fundamentals/valu improv
neutral industri coverag univers fundamentals/valu steadi neither improv deterior
neg industri coverag univers fundamentals/valu deterior
distribut rate
barclay equiti research compani coverag
assign overw eight rate hich purpos mandatori regulatori disclosur classifi buy
